| 영문 | exchange transfusion | 한글 | 교환수혈 |
|---|---|---|---|
| 설명 | 한쪽으로는 피를 뽑아내면서 다른 쪽으로는 같은 양의 피를 넣어 온몸의 피를 갈아 넣는 수혈방법. 갓난아이의 용혈병의 치료법으로 쓴다. |
||
| 영문 | guanine | 한글 | 구아닌 |
|---|---|---|---|
| 설명 | DNA나 RNA의 구성요소로 염기 중의 하나. |
||
| 영문 | rheumatoid factor | 한글 | 류마티스 인자 |
|---|---|---|---|
| 설명 | IgG의 Fc부위에 있는 항원결정인자에 대한 항체로서 전형적인 또는 확실한 류마티스관절염(rheumatoid arthritis) 환자의 80%에서 발견된다. 류마티스 인자는 IgM, IgG, IgA중 하나가 될 수 있으나 주로 IgM이다. 소아류마티스관절염(juvenile rheumatoid arthritis: 소아기에 발생하는 류마티스관절염)을 비롯한, 다른 결합조직병이나 감염병에도 나타날 수 있다 |
||
| 영문 | growth factor | 한글 | 성장인자 |
|---|---|---|---|
| 설명 | 세포의 분화 및 성장에 관여하는 단백질. 성장인자는 정상 세포주기에 필수적이기 때문에 동물의 생명에 중대한 요소가 된다. 무엇보다도 성장인자는 태아의 발육을 조정하고 조직의 유지 및 보수에 중대한 역할을 하며, 혈구의 생성을 자극한다. 또한 암의 진행과정에도 관여한다. |
||
| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| GN | gaze nystagmus; glomerulonephritis; glucose nitrogen [ratio]; gnotobiote; graduate nurse; gram-negat... |
| GNAT | guanine nucleotide-binding protein, alpha-transducing |
| GNB | ganglioneuroblastoma; gram-negative bacillus; guanine nucleotide-binding [protein] |
| GNBT | guanine nucleotide-binding protein, beta transducing |
| GEF | Guanine nucleotide Exchange Factors |
|---|---|
| GEP | guanine nucleotide exchange protein |
| RAL | Relative adduct labeling |
| GDI | Guanine nucleotide dissociation inhibitor |
| G-protein | Guanine nucleotide-binding protein |
| ral | <oncogene> Oncogene related to ras. (18 Nov 1997) |
|---|---|
| guanine | <biochemistry, molecular biology> One of the constituent bases of nucleic acids, nucleosides and nucleotides. (18 Nov 1997) |
| guanine aminase | <enzyme> An enzyme that catalyses the deamination of guanine to form xanthine. Chemical name: Guanine aminohydrolase Registry number: EC 3.5.4.3 (12 Dec 1998) |
| guanine cell | A cell whose cytoplasm contains glistening crystals of guanine. (05 Mar 2000) |
| guanine deaminase | <enzyme> An enzyme that catalyses the deamination of guanine to form xanthine. Chemical name: Guanine aminohydrolase Registry number: EC 3.5.4.3 (12 Dec 1998) |
| guanine deoxyribonucleotide | Deoxyguanosine monophosphate, a hydrolysis product of DNA. Synonym: guanine deoxyribonucleotide. (05 Mar 2000) |
| guanine ribonucleotide | A major component of ribonucleic acids. Synonym: guanine ribonucleotide, guanosine 5'-monophosphate. Guanylic acid reductase (GMP reductase), an enzyme that catalyses the reaction of GMP with NADPH producing IMP, NH3, and NADP+; a part of the purine salvage pathway. Guanylic acid synthetase (GMP synthetase), an enzyme catalyzing the reaction of l-glutamine, XMP, and ATP to produce GMP, l-glutamate, AMP, and pyrophosphate; a key step in purine biosynthesis. Acronym: GMP (05 Mar 2000) |
| mRNA (guanine(N7))-methyltransferase | <enzyme> Catalyses s-adenosyl-l-methionine and g(5')pppr-RNA to yield s-adenosyl-l-homocysteine and m(7)g(5')pppr-RNA; mRNA containing an n(7)-methylguanine cap Registry number: EC 2.1.1.56 Synonym: mRNA (guanine-7-)methyltransferase, mRNA(guanine-7-)methyltransferase, RNA (guanine-7) methyltransferase, abd1 gene product (26 Jun 1999) |
| pyrimidine-guanine sequence-specific ribonuclease | <enzyme> From yolk granules of adult rana catesbeiana oocytes Registry number: EC 3.1.27.- Synonym: rc-rnase, rana catesbeiana rnase (26 Jun 1999) |
| hypoxanthine-guanine phosphoribosyl tranferase marker | The gene which codes for the enzyme hypoxanthine-guanine phosphoribosyl transferase. It is a selectable marker because cells which have a defective version of this gene are resistant to poisoning by toxic purine derivatives which result from the metabolic pathway that the HGPRT enzyme catalyses. (The purine derivatives are toxic because they incorporate into DNA as a result of the HGPRT enzyme's actions). Because the defective gene cannot produce the enzyme, no toxic purine derivatives are produced, the gene can therefore be selected for. (09 Oct 1997) |
| hypoxanthine guanine phosphoribosyltransferase | <enzyme> An enzyme that catalyses the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or 6-mercaptopurine to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the lesch-nyhan syndrome, while partial deficiency results in overproduction of uric acid. Chemical name: IMP:pyrophosphate phospho-D-ribosyltransferase Registry number: EC 2.4.2.8 (12 Dec 1998) |
| hypoxanthine-guanine phosphoribosyl transferase | <enzyme> An enzyme which plays an important role in the making of ATP and GTP from guanine -- the only way guanine, adenine, or other purine molecules are able to become part of nucleic acids. Biologists study gene action via the incorporation of modified nitrogenous bases into DNA by manipulating the metabolic role which this enzyme plays. Similarly, the enzyme thymidine kinase is used for the same purpose by biologists because it fills the same important and unique role for the pyrimidines (thymine, cytosine, uracil, etc.). Acronym: HGPRT (09 Oct 1997) |
| hypoxanthine guanine phosphoribosyltransferase deficiency | A sex-linked inherited metabolic disorder; complete deficiency results in Lesch-Nyhan syndrome; incomplete deficiency is associated with acute gouty arthritis and renal stones. (05 Mar 2000) |
| hypoxanthine-guanine-xanthine phosphoribosyltransferase | <enzyme> From tritrichomonas foetus; in contrast to EC 2.4.2.8, this enzyme also uses xanthine as substrate; mw 24 kD Registry number: EC 2.4.2.- Synonym: hgxprtase (26 Jun 1999) |
| anion exchange | The process by which an anion in a mobile (liquid) phase exchanges with another anion previously bound to a solid, positively charged phase, the latter being an anion exchanger. It takes place when Cl- is exchanged for OH- in desalting. The reaction is Cl- (in solution) + (OH- on anion exchanger+) → (Cl- on anion exchanger) + OH- (in solution); combined with cation exchange, NaCl is removed from solution. Anion exchange may also be used chromatographically, to separate anions, and medicinally, to remove an anion (e.g., Cl-) from gastric contents or bile acids in the intestine. (05 Mar 2000) |
Synonyms : ral-GDS, ral GDS
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|